Cargando…

Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions

Antibodies perform both neutralizing and non-neutralizing effector functions that protect against certain pathogen-induced diseases. A human antibody directed at the SARS-CoV-2 Spike N-terminal domain (NTD), DH1052, was recently shown to be non-neutralizing yet it protected mice and cynomolgus macaq...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pierre, Camille N., Adams, Lily E., Anasti, Kara, Goodman, Derrick, Stanfield-Oakley, Sherry, Powers, John M., Li, Dapeng, Rountree, Wes, Wang, Yunfei, Edwards, Robert J., Munir Alam, S., Ferrari, Guido, Tomaras, Georgia D., Haynes, Barton F., Baric, Ralph S., Saunders, Kevin O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402036/ https://www.ncbi.nlm.nih.gov/pubmed/37546738 http://dx.doi.org/10.1101/2023.07.25.550460

Ejemplares similares

Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s
por: Tolbert, William D., et al.
Publicado: (2022)

Additional boosting to the RV144 vaccine regimen increased Fc-mediated effector function magnitude but not durability
por: Shubin, Zhanna, et al.
Publicado: (2023)

Incorporating the Cluster A and V1V2 Targets into a Minimal Structural Unit of the HIV-1 Envelope to Elicit a Cross-Clade Response with Potent Fc-Effector Functions
por: Sherburn, Rebekah, et al.
Publicado: (2021)

Vaccine-Induced Antibodies Mediate Higher Antibody-Dependent Cellular Cytotoxicity After Interleukin-15 Pretreatment of Natural Killer Effector Cells
por: Fisher, Leigh, et al.
Publicado: (2019)

Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial
por: Tolbert, William D., et al.
Publicado: (2020)

Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions
por: Shiakolas, Andrea R., et al.
Publicado: (2021)

Advancing Toward HIV-1 Vaccine Efficacy through the Intersections of Immune Correlates
por: Tomaras, Georgia D., et al.
Publicado: (2013)

Isolation of HIV-1-Neutralizing Mucosal Monoclonal Antibodies from Human Colostrum
por: Friedman, James, et al.
Publicado: (2012)

Erratum for Tolbert et al., “Recognition Patterns of the C1/C2 Epitopes Involved in Fc-Mediated Response in HIV-1 Natural Infection and the RV114 Vaccine Trial”
por: Tolbert, William D., et al.
Publicado: (2021)

HIV-1 Vpu restricts Fc-mediated effector functions in vivo
por: Prévost, Jérémie, et al.
Publicado: (2022)

B cells expressing IgM B cell receptors of HIV-1 neutralizing antibodies discriminate antigen affinities by sensing binding association rates
por: Hossain, Md. Alamgir, et al.
Publicado: (2022)

Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage
por: Henderson, Rory, et al.
Publicado: (2023)

Selection of HIV Envelope Strains for Standardized Assessments of Vaccine-Elicited Antibody-Dependent Cellular Cytotoxicity-Mediating Antibodies
por: Mielke, Dieter, et al.
Publicado: (2022)

Broadly binding and functional antibodies and persisting memory B cells elicited by HIV vaccine PDPHV
por: Wang, Shixia, et al.
Publicado: (2022)

Selection of immunoglobulin elbow region mutations impacts interdomain conformational flexibility in HIV-1 broadly neutralizing antibodies
por: Henderson, Rory, et al.
Publicado: (2019)

Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
por: Saunders, Kevin O., et al.
Publicado: (2021)

Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates
por: Saunders, Kevin O., et al.
Publicado: (2021)

Humoral and Innate Antiviral Immunity as Tools to Clear Persistent HIV Infection
por: Ferrari, Guido, et al.
Publicado: (2017)

Fc-Engineered Antibodies with Enhanced Fc-Effector Function for the Treatment of B-Cell Malignancies
por: van der Horst, Hilma J., et al.
Publicado: (2020)

Qualified Biolayer Interferometry Avidity Measurements Distinguish the Heterogeneity of Antibody Interactions with Plasmodium falciparum Circumsporozoite Protein Antigens
por: Dennison, S. Moses, et al.
Publicado: (2018)

Vector induced skewing of antibody Fc-effector functions
por: Chung, A, et al.
Publicado: (2012)

Antigen-dependent modulation of immune responses to antigen-Fc fusion proteins by Fc-effector functions
por: Richel, Elie, et al.
Publicado: (2023)

Induction of Antibodies in Rhesus Macaques That Recognize a Fusion-Intermediate Conformation of HIV-1 gp41
por: Dennison, S. Moses, et al.
Publicado: (2011)

Polymeric human Fc-fusion proteins with modified effector functions
por: Mekhaiel, David N. A., et al.
Publicado: (2011)

IgG Fc engineering to modulate antibody effector functions
por: Wang, Xinhua, et al.
Publicado: (2017)

Asymmetric Fc Engineering for Bispecific Antibodies with Reduced Effector Function
por: Escobar-Cabrera, Eric, et al.
Publicado: (2017)

Engineered Fc-glycosylation switch to eliminate antibody effector function
por: Zhou, Qun, et al.
Publicado: (2020)

Fc-engineered antibodies with immune effector functions completely abolished
por: Wilkinson, Ian, et al.
Publicado: (2021)

The immune response during acute HIV-1 infection: clues for vaccine development
por: McMichael, Andrew J., et al.
Publicado: (2009)

Mouse and human antibodies bind HLA-E-leader peptide complexes and enhance NK cell cytotoxicity
por: Li, Dapeng, et al.
Publicado: (2022)

Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles
por: Brown, Eric P., et al.
Publicado: (2017)

Serum IgA Fc effector functions in infectious disease and cancer
por: Davis, Samantha K, et al.
Publicado: (2020)

Fc-Engineering for Modulated Effector Functions—Improving Antibodies for Cancer Treatment
por: Liu, Rena, et al.
Publicado: (2020)

Building a better antibody through the Fc: advances and challenges in harnessing antibody Fc effector functions for antiviral protection
por: Gunn, Bronwyn M., et al.
Publicado: (2021)

A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice
por: Martinez, David R., et al.
Publicado: (2021)

Security for Microsoft Windows system administrators: introduction to key information security concepts
por: Rountree, Derrick
Publicado: (2011)

Federated identity primer
por: Rountree, Derrick
Publicado: (2013)

Windows 2012 Server network security: securing your Windows network systems and infrastructure
por: Rountree, Derrick
Publicado: (2013)

Immunogenicity, safety, and efficacy of sequential immunizations with an SIV-based IDLV expressing CH505 Envs
por: Blasi, Maria, et al.
Publicado: (2020)

Fcγ receptor-dependent antibody effector functions are required for vaccine protection against infection by antigenic variants of SARS-CoV-2
por: Mackin, Samantha R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tiohsntah587h3vnegdnsctrgk